Related Experiment Video
Updated: Jul 8, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Age at menopause of HIV-infected women: a review
Délio Marques Conde1, Aarão Mendes Pinto-Neto, Lúcia Costa-Paiva
1Department of Gynecology and Obstetrics, Universidade Federal de Goiás, Goiânia, Goíás, Brazil. condedelio@uol.com.br
Abstract:
The advent of highly active antiretroviral therapy has promoted a reduction in mortality due to HIV. Thus more women are living longer after receiving a diagnosis of HIV infection. With an increase in survival, topics related to the menopausal transition in HIV-infected women have emerged, such as age at menopause, bone mineral density and menopause-related symptoms. To this end, several studies have investigated age at menopause (AM) in HIV-infected women. The present paper reviews these studies and discusses the possible clinical implications of determining AM for HIV-positive women.
Related Concept Videos
Menopause
Retrovirus Life Cycles
Sexually Transmitted Infections
Cryptococcal Meningitis
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of endometrial...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

